JP2007238598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007238598A5 JP2007238598A5 JP2006307035A JP2006307035A JP2007238598A5 JP 2007238598 A5 JP2007238598 A5 JP 2007238598A5 JP 2006307035 A JP2006307035 A JP 2006307035A JP 2006307035 A JP2006307035 A JP 2006307035A JP 2007238598 A5 JP2007238598 A5 JP 2007238598A5
- Authority
- JP
- Japan
- Prior art keywords
- stroke
- patient
- composition
- composition according
- history
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000006011 Stroke Diseases 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 3
- 125000004494 ethyl ester group Chemical group 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 108010023302 HDL Cholesterol Proteins 0.000 claims 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006307035A JP5069448B2 (ja) | 2006-02-07 | 2006-11-13 | 脳卒中再発予防用組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006029954 | 2006-02-07 | ||
| JP2006029954 | 2006-02-07 | ||
| JP2006307035A JP5069448B2 (ja) | 2006-02-07 | 2006-11-13 | 脳卒中再発予防用組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006194043A Division JP4005104B2 (ja) | 2006-02-07 | 2006-07-14 | 脳卒中再発予防用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007238598A JP2007238598A (ja) | 2007-09-20 |
| JP2007238598A5 true JP2007238598A5 (enExample) | 2009-08-20 |
| JP5069448B2 JP5069448B2 (ja) | 2012-11-07 |
Family
ID=38584473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006307035A Active JP5069448B2 (ja) | 2006-02-07 | 2006-11-13 | 脳卒中再発予防用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5069448B2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5924834B2 (ja) | 2008-09-02 | 2016-05-25 | アマリン ファーマシューティカルズ アイルランド リミテッド | エイコサペンタエン酸およびニコチン酸を含む製薬組成物ならびにこの製薬組成物を用いる方法 |
| NZ734905A (en) | 2009-04-29 | 2019-05-31 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| HUE034941T2 (en) | 2009-04-29 | 2018-03-28 | Amarin Pharmaceuticals Ie Ltd | Stable pharmaceutical composition and methods of using same |
| EP3318255B1 (en) | 2009-06-15 | 2021-03-10 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating stroke in a subject on concomitant statin therapy |
| US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| WO2012074930A2 (en) | 2010-11-29 | 2012-06-07 | Amarin Pharma, Inc. | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| MX392694B (es) | 2012-06-29 | 2025-03-24 | Amarin Pharmaceuticals Ie Ltd | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina |
| WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
| US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
| JP7020756B2 (ja) | 2018-09-24 | 2022-02-16 | アマリン ファーマシューティカルズ アイルランド リミテッド | 対象の心血管イベントのリスクを低減する方法 |
| WO2021097120A1 (en) | 2019-11-12 | 2021-05-20 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter |
| WO2022225896A1 (en) | 2021-04-21 | 2022-10-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022713B2 (en) * | 2004-02-19 | 2006-04-04 | Kowa Co., Ltd. | Hyperlipemia therapeutic agent |
-
2006
- 2006-11-13 JP JP2006307035A patent/JP5069448B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007238598A5 (enExample) | ||
| RU2470016C2 (ru) | Производное бипиразола | |
| ATE510537T1 (de) | Pharmazeutische zusammensetzungen von entacapon, levodopa und carbidopa mit verbesserter bioverfügbarkeit | |
| JP2012517449A5 (enExample) | ||
| JP2006504795A5 (enExample) | ||
| NZ807894A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| FI3782612T3 (fi) | Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi | |
| JP2007523049A5 (enExample) | ||
| ME02662B (me) | Niskofrekventna terapija glatiramer acetatom | |
| UA110012C2 (uk) | Лікарські форми для перорального застосування, що містять ацетат лікарбазепіну | |
| HRP20151202T1 (hr) | Oralna formulacija metadoksina | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| WO2007012022A3 (en) | Unit dose form with ibuprofen-famotidine admixture | |
| EP1957081A4 (en) | PHARMACEUTICAL DOSAGE FORM FOR THE ORAL TRACT INCLUDING AS ACTIVE INGREDIENTS A PROTON INHIBITOR PUMP AND ACETYLSALICYLIC ACID INHIBITOR | |
| HRP20110497T4 (hr) | Postupci za primjenu kompozicija aminopiridina sa produženim oslobađanjem | |
| HRP20170734T1 (hr) | Povećana biodostupnost lijeka u terapiji naltreksonom | |
| MA28862B1 (fr) | Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif | |
| MX2009004579A (es) | Composicion farmaceutica que tiene actividad antisicotica, antidepresiva o antiepileptica, con efecto colateral reducido. | |
| WO2008075320A3 (en) | Antilipidemic pharmaceutical compositions and process for preparation thereof | |
| JP2008266291A5 (enExample) | ||
| JP2009516719A5 (enExample) | ||
| ATE410152T1 (de) | Therapeutisches system mit amoxicillin und clavulansäure | |
| JP2012097036A5 (enExample) | ||
| WO2009019307A3 (en) | Oral calcitonin compositions and applications thereof |